Stem cell clinics in the UK: a web-based study

Sami Kamel; Kevin R Smith

doi:10.2217/rme-2021-0072

Stem cell clinics in the UK: a web-based study

Sami Kamel, Kevin R Smith^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

184 Downloads (Pure)

Abstract

Aim: Explore the nature and extent of web-based promotion of stem cell treatments marketed by clinics in the UK. Materials & methods: Web-based analysis of clinics in the UK using predefined variables, with analysis of eligible clinics according to preset criteria of ethical relevance. Results: A majority (79%) of UK clinics were judged to be problematic. Information was found to be lacking, misleading or otherwise problematic in several respects, including a lack of information on risks of adverse effects, unjustifiably optimistic depictions of therapeutic effectiveness, and questionable presentational approaches such as the use of celebrity patient testimonials. Conclusion: In a majority of cases, commercial clinics in the UK portray stem cell therapies on their websites in ethically questionable ways.

Original language	English
Pages (from-to)	1029-1036
Number of pages	8
Journal	Regenerative Medicine
Volume	16
Issue number	12
Early online date	11 Nov 2021
DOIs	https://doi.org/10.2217/rme-2021-0072
Publication status	Published - 1 Dec 2021

Keywords

Direct-to-consumer
Ethics
Informed consent
Legislation
Marketing
Policy
Stem cells

Access to Document

10.2217/rme-2021-0072

Smith_StemCellClinics_Accepted_2021Accepted author manuscript, 545 KB

Cite this

@article{5b3f95f047f04563aea74b7f72820650,

title = "Stem cell clinics in the UK: a web-based study",

abstract = "Aim: Explore the nature and extent of web-based promotion of stem cell treatments marketed by clinics in the UK. Materials & methods: Web-based analysis of clinics in the UK using predefined variables, with analysis of eligible clinics according to preset criteria of ethical relevance. Results: A majority (79%) of UK clinics were judged to be problematic. Information was found to be lacking, misleading or otherwise problematic in several respects, including a lack of information on risks of adverse effects, unjustifiably optimistic depictions of therapeutic effectiveness, and questionable presentational approaches such as the use of celebrity patient testimonials. Conclusion: In a majority of cases, commercial clinics in the UK portray stem cell therapies on their websites in ethically questionable ways.",

author = "Sami Kamel and Smith, {Kevin R}",

note = "Publisher Copyright: {\textcopyright} 2021 Future Medicine Ltd.",

year = "2021",

month = dec,

day = "1",

doi = "10.2217/rme-2021-0072",

language = "English",

volume = "16",

pages = "1029--1036",

journal = "Regenerative Medicine",

issn = "1746-0751",

publisher = "Future Medicine Ltd.",

number = "12",

}

TY - JOUR

T1 - Stem cell clinics in the UK

T2 - a web-based study

AU - Kamel, Sami

AU - Smith, Kevin R

PY - 2021/12/1

Y1 - 2021/12/1

N2 - Aim: Explore the nature and extent of web-based promotion of stem cell treatments marketed by clinics in the UK. Materials & methods: Web-based analysis of clinics in the UK using predefined variables, with analysis of eligible clinics according to preset criteria of ethical relevance. Results: A majority (79%) of UK clinics were judged to be problematic. Information was found to be lacking, misleading or otherwise problematic in several respects, including a lack of information on risks of adverse effects, unjustifiably optimistic depictions of therapeutic effectiveness, and questionable presentational approaches such as the use of celebrity patient testimonials. Conclusion: In a majority of cases, commercial clinics in the UK portray stem cell therapies on their websites in ethically questionable ways.

AB - Aim: Explore the nature and extent of web-based promotion of stem cell treatments marketed by clinics in the UK. Materials & methods: Web-based analysis of clinics in the UK using predefined variables, with analysis of eligible clinics according to preset criteria of ethical relevance. Results: A majority (79%) of UK clinics were judged to be problematic. Information was found to be lacking, misleading or otherwise problematic in several respects, including a lack of information on risks of adverse effects, unjustifiably optimistic depictions of therapeutic effectiveness, and questionable presentational approaches such as the use of celebrity patient testimonials. Conclusion: In a majority of cases, commercial clinics in the UK portray stem cell therapies on their websites in ethically questionable ways.

U2 - 10.2217/rme-2021-0072

DO - 10.2217/rme-2021-0072

M3 - Article

SN - 1746-0751

VL - 16

SP - 1029

EP - 1036

JO - Regenerative Medicine

JF - Regenerative Medicine

IS - 12

ER -

Stem cell clinics in the UK: a web-based study

Abstract

Keywords

Access to Document

Fingerprint

Cite this